Dr. Pasindu Samarasinghe, MBBS
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,765 | 65 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $835.02 | 8 | $0 (2024) |
| ABBVIE INC. | $510.47 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $417.82 | 4 | $0 (2024) |
| Medtronic, Inc. | $266.85 | 3 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $260.64 | 2 | $0 (2023) |
| Gilead Sciences, Inc. | $247.20 | 3 | $0 (2022) |
| Novo Nordisk Inc | $172.39 | 5 | $0 (2022) |
| Amgen Inc. | $146.26 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $136.88 | 1 | $0 (2021) |
| Phathom Pharmaceuticals, Inc. | $136.48 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,271 | 17 | AstraZeneca Pharmaceuticals LP ($554.80) |
| 2023 | $1,131 | 17 | AbbVie Inc. ($260.86) |
| 2022 | $835.10 | 14 | Gilead Sciences, Inc. ($230.03) |
| 2021 | $459.30 | 13 | Janssen Pharmaceuticals, Inc ($136.88) |
| 2020 | $49.11 | 3 | E.R. Squibb & Sons, L.L.C. ($22.14) |
| 2019 | $19.43 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($19.43) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: VACCINE | ||||||
| 11/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: VACCINES | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $121.28 | General |
| Category: RESPIRATORY | ||||||
| 08/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $116.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/02/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: VACCINES | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $108.34 | General |
| Category: Respiratory | ||||||
| 05/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/09/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $103.61 | General |
| Category: VACCINES | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $114.71 | General |
| Category: Respiratory | ||||||
| 04/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: VACCINES | ||||||
| 04/12/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.91 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: VACCINES | ||||||
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $83.15 | General |
| Category: Respiratory | ||||||
| 02/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $123.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 12/01/2023 | Myriad Women's Health, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $68.31 | General |
| Category: ONCOLOGY | ||||||
| 11/29/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $92.60 | General |
| Category: NEUROLOGY | ||||||
| 11/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Gastroenterology | ||||||
| 11/02/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $80.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diabetes | ||||||
| 09/22/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.43 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $37.02 | General |
| Category: Sacral Nerve Stimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 3,056 | 4,325 | $456,073 | $123,686 |
| 2022 | 41 | 3,181 | 4,450 | $468,901 | $135,549 |
| 2021 | 42 | 3,307 | 4,212 | $447,954 | $135,065 |
| 2020 | 31 | 2,141 | 2,500 | $262,883 | $72,495 |
All Medicare Procedures & Services
150 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 291 | 648 | $196,992 | $38,068 | 19.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 227 | 227 | $81,266 | $32,725 | 40.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 25 | 113 | $21,809 | $5,763 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 88 | 100 | $20,600 | $5,320 | 25.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 239 | 297 | $16,929 | $4,889 | 28.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 253 | 422 | $15,192 | $4,360 | 28.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 265 | 509 | $5,008 | $4,187 | 83.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 119 | 126 | $12,726 | $3,605 | 28.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 228 | 260 | $11,960 | $3,398 | 28.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 237 | 339 | $9,153 | $2,569 | 28.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 221 | 269 | $8,877 | $2,531 | 28.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 35 | 35 | $5,705 | $2,446 | 42.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 28 | 28 | $5,768 | $1,601 | 27.8% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 73 | 87 | $5,481 | $1,568 | 28.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 36 | 36 | $2,628 | $1,247 | 47.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 17 | 19 | $5,776 | $1,144 | 19.8% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 52 | 52 | $3,276 | $970.63 | 29.6% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 48 | 69 | $3,174 | $921.84 | 29.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 20 | 20 | $4,600 | $898.40 | 19.5% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 15 | 15 | $885.00 | $678.45 | 76.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $1,314 | $623.34 | 47.4% |
| 83550 | Iron binding capacity | Office | 2023 | 48 | 69 | $2,070 | $591.33 | 28.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 55 | 56 | $3,752 | $576.32 | 15.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 16 | 17 | $1,500 | $497.33 | 33.2% |
| 83540 | Iron level | Office | 2023 | 48 | 69 | $1,518 | $437.46 | 28.8% |
About Dr. Pasindu Samarasinghe, MBBS
Dr. Pasindu Samarasinghe, MBBS is a Student in an Organized Health Care Education/Training Program healthcare provider based in Rockville, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2016. The National Provider Identifier (NPI) number assigned to this provider is 1598127003.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pasindu Samarasinghe, MBBS has received a total of $3,765 in payments from pharmaceutical and medical device companies, with $1,271 received in 2024. These payments were reported across 65 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,765).
As a Medicare-enrolled provider, Samarasinghe has provided services to 11,685 Medicare beneficiaries, totaling 15,487 services with total Medicare billing of $466,795. Data is available for 4 years (2020–2023), covering 150 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Rockville, MD
- Active Since 03/23/2016
- Last Updated 05/20/2019
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1598127003
Products in Payments
- AIRSUPRA (Drug) $431.19
- FARXIGA (Drug) $302.40
- QUVIVIQ (Drug) $260.64
- VRAYLAR (Drug) $249.93
- SHINGRIX (Biological) $181.53
- UBRELVY (Drug) $164.07
- XARELTO (Drug) $136.88
- VOQUEZNA (Drug) $136.48
- Repatha (Biological) $125.00
- Biktarvy (Drug) $121.87
- AREXVY (Drug) $121.28
- CLOSUREFAST (Device) $115.85
- ClosureFast (Device) $113.98
- Descovy (Drug) $108.16
- Rybelsus (Drug) $101.75
- BREZTRI (Drug) $101.43
- Vivitrol (Drug) $98.43
- QULIPTA (Drug) $96.47
- INSPIRE (Device) $92.60
- MYRISK (Device) $68.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Rockville
Jay Rhee
Student in an Organized Health Care Education/Training Program — Payments: $141,592
Nadia Yusuf, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $21,392
Jay Bronder, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $12,128
Andrew Rogers
Student in an Organized Health Care Education/Training Program — Payments: $5,250
Dr. Jeffrey Kim, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,862
Dr. Sahil Sekhon, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $3,680